A genetic enrichment strategy for delay of onset of Alzheimer’s disease clinical trials: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation

A genetic enrichment strategy for delay of onset of Alzheimer’s disease clinical trials Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation

Saved in:
Bibliographic Details
Published in:Alzheimer's & dementia Vol. 16; no. S5
Main Authors: Lutz, Michael W., Burns, Daniel K., Alexander, Robert, Culp, Meredith, Yarnall, David, Haneline, Stephen, Chiang, Carl, Lai, Eric, Metz, Craig, Sundseth, Scott, Guennel, Tobi, Marshall, Scott, Andruss, Bernard F., Latham, Gary J., Hall, Bradley, Statt, Sarah N., Swanson, Tom, Ratti, Emiliangelo, Saunders, Ann M.
Format: Journal Article
Language:English
Published: 01-12-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Andruss, Bernard F.
Lutz, Michael W.
Ratti, Emiliangelo
Lai, Eric
Marshall, Scott
Statt, Sarah N.
Chiang, Carl
Saunders, Ann M.
Yarnall, David
Latham, Gary J.
Swanson, Tom
Hall, Bradley
Burns, Daniel K.
Alexander, Robert
Haneline, Stephen
Metz, Craig
Guennel, Tobi
Culp, Meredith
Sundseth, Scott
Author_xml – sequence: 1
  givenname: Michael W.
  surname: Lutz
  fullname: Lutz, Michael W.
  organization: Duke University School of Medicine Durham NC USA
– sequence: 2
  givenname: Daniel K.
  surname: Burns
  fullname: Burns, Daniel K.
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 3
  givenname: Robert
  surname: Alexander
  fullname: Alexander, Robert
  organization: Takeda Development Center Americas, Inc. Cambridge MA USA
– sequence: 4
  givenname: Meredith
  surname: Culp
  fullname: Culp, Meredith
  organization: Takeda Development Center Americas, Inc. Cambridge MA USA
– sequence: 5
  givenname: David
  surname: Yarnall
  fullname: Yarnall, David
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 6
  givenname: Stephen
  surname: Haneline
  fullname: Haneline, Stephen
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 7
  givenname: Carl
  surname: Chiang
  fullname: Chiang, Carl
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 8
  givenname: Eric
  surname: Lai
  fullname: Lai, Eric
  organization: Takeda Development Center Americas, Inc. Cambridge MA USA
– sequence: 9
  givenname: Craig
  surname: Metz
  fullname: Metz, Craig
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 10
  givenname: Scott
  surname: Sundseth
  fullname: Sundseth, Scott
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 11
  givenname: Tobi
  surname: Guennel
  fullname: Guennel, Tobi
  organization: QuartzBio, part of Precision for Medicine Frederick MD USA
– sequence: 12
  givenname: Scott
  surname: Marshall
  fullname: Marshall, Scott
  organization: QuartzBio, part of Precision for Medicine Frederick MD USA
– sequence: 13
  givenname: Bernard F.
  surname: Andruss
  fullname: Andruss, Bernard F.
  organization: Asuragen Austin TX USA
– sequence: 14
  givenname: Gary J.
  surname: Latham
  fullname: Latham, Gary J.
  organization: Asuragen Austin TX USA
– sequence: 15
  givenname: Bradley
  surname: Hall
  fullname: Hall, Bradley
  organization: Asuragen Austin TX USA
– sequence: 16
  givenname: Sarah N.
  surname: Statt
  fullname: Statt, Sarah N.
  organization: Asuragen Austin TX USA
– sequence: 17
  givenname: Tom
  surname: Swanson
  fullname: Swanson, Tom
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
– sequence: 18
  givenname: Emiliangelo
  surname: Ratti
  fullname: Ratti, Emiliangelo
  organization: Takeda Development Center Americas, Inc. Cambridge MA USA
– sequence: 19
  givenname: Ann M.
  surname: Saunders
  fullname: Saunders, Ann M.
  organization: Zinfandel Pharmaceuticals, Inc. Chapel Hill NC USA
BookMark eNqVjjFuAjEQAC1EJCChyQu2RgLWl7sQSoSI8gAaKssye2Dks9Gum6PKN_geLwEESp9qpphiBqobUySl3jVONGIxteE0wbKcF9hRfV1VxbgqZvPun39iTw1EDoglfumqrzYL2FGk7B1QZO_2DcUMktlm2rVQJ4YtBdtCqiFFoXyXRTjtyTfEl9-zwNYLWSFwwUfvbIDM3gZ5Uy_1DTR88lWNvlfr5c_YcRJhqs2RfWO5NRrNfd7c5s1j_uNf8RUcDk7z
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1002/alz.044920
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 1552-5279
ExternalDocumentID 10_1002_alz_044920
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1OC
1~.
1~5
24P
33P
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X7
8FI
8FJ
8P~
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAXLA
AAXUO
AAYXX
ABBQC
ABCQJ
ABCUV
ABIVO
ABJNI
ABMAC
ABMZM
ABUWG
ACCFJ
ACCZN
ACGFS
ACGOF
ACPOU
ACXQS
ADBBV
ADBTR
ADEZE
ADHUB
ADKYN
ADMUD
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AEVXI
AFKRA
AFTJW
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
AZQEC
BENPR
BFHJK
BLXMC
C45
CCPQU
CITATION
DCZOG
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYUFA
G-Q
GBLVA
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
K9-
LATKE
LEEKS
M0R
M41
MO0
MOBAO
N9A
NAPCQ
O-L
O9-
OAUVE
OVD
OVEED
OZT
P-8
P-9
P2P
PC.
PGMZT
PIMPY
PSYQQ
Q38
QTD
RIG
ROL
RPM
RPZ
SDF
SDG
SEL
SES
SSZ
SUPJJ
T5K
TEORI
UKHRP
~G-
ID FETCH-crossref_primary_10_1002_alz_0449203
ISSN 1552-5260
IngestDate Fri Nov 22 00:34:30 EST 2024
IsPeerReviewed true
IsScholarly true
Issue S5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-crossref_primary_10_1002_alz_0449203
ParticipantIDs crossref_primary_10_1002_alz_044920
PublicationCentury 2000
PublicationDate 2020-12-00
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-12-00
PublicationDecade 2020
PublicationTitle Alzheimer's & dementia
PublicationYear 2020
SSID ssj0040815
Score 4.655295
SourceID crossref
SourceType Aggregation Database
Subtitle Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation
Title A genetic enrichment strategy for delay of onset of Alzheimer’s disease clinical trials
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NS8MwGA7bvHgRRcVvAnpydHZJtzXHopOBHwgbqKfSrikrjG3Y9bKTf8O_5y_xTdIkRT3Mg5dQ0qZN-j4kb_J-PAhd0CTlbjtmDgMEOV5KuBMlXeK4MejaDADUjsVR9mDYe3zxb_pev1bTwX627l8lDXUgaxE5-wdpm5dCBVyDzKEEqUO5ltwDQYosIhOb8EQ2nkhjf65y0CrnTJEXUtrVhSO1dAQIpqsJzwSPSun6wHJtubGhk5LfI68qs7aZOPQXGErkYWNmpvr7QtLFauf85nPLbP9hKLmNcW_emTsm5MY6fhtDSTGVdHoPgmA0W06qRxak6v5RzrIdsQNWRAItXq1TzDJmau5WIDjs_DrlqxSy0XTVcj2PEdcubNqY_229M16IKmMzCaFtqNrW0Qb0gAoOBkqf9IrugdrUkXl3y26bNLfkyn63othUNJTRNtoqtxY4UJjYQTU-20WvAS7xgC0esMYDBjxgiQc8T7HEg7gwgv18_8hxiQSskYAVEvbQ5W1_dD1wdH_ChcpcEv4cMd1Hjdl8xg8Q9iPickZh2Yl9L4m534tSRlLeHUfM5dQ_ROdrvPBoraeO0aYFxglqLN8KforqeVKcyV__BScbVjY
link.rule.ids 315,782,786,27934,27935
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+genetic+enrichment+strategy+for+delay+of+onset+of+Alzheimer%E2%80%99s+disease+clinical+trials&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Lutz%2C+Michael+W.&rft.au=Burns%2C+Daniel+K.&rft.au=Alexander%2C+Robert&rft.au=Culp%2C+Meredith&rft.date=2020-12-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=16&rft.issue=S5&rft_id=info:doi/10.1002%2Falz.044920&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_alz_044920
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon